2020 Speakers

Anansa is the Co-Founder and Product Lead at QuikPath. She has developed the technology used in the platform and is focused on continued Product improvement and commercialization. With a Ph.D. in Material Science and  Masters in Biotechnology, she has been involved in Research and Development of...

Massimo Alberti is the founder and CEO of REVIVO Biosystems. Massimo holds a M.Sc. in Biomedical Engineering from the Politecnico di Milano (Italy) and a Ph.D. in Micro and Nanotechnology from the Technical University of Denmark. After working as a Business Developer at Kem-En-Tec Diagnostics, a...

Jitesh is a clinician and practices in technology driven Disease Management, Digital Therapeutics and Health-IT domain.  The solution/service delivery journey begins at therapy research leading to covering nuances of user journey, user interaction design, engagement, retention, program...

Martin-Immanuel Bittner is a Co-Founder and CEO of Arctoris, the world's first fully automated cloud lab for drug discovery. He graduated as a medical doctor from the University of Freiburg in Germany, followed by his DPhil in Oncology as a Rhodes scholar at the University of...

Jerome Boyd-Kirkup is the Co-founder and Chief Scientific Officer of Hummingbird Bioscience, an innovative systems biology enabled biotechnology company. He is responsible for overseeing the development of new technologies and intellectual property, designing experimental strategies for drug...

Angela Brady is Innovation Research Director at GSK Consumer Health, where she is responsible for building the pipeline of consumer relevant, scientifically differentiated products in the areas of OTC medicines, natural products and medical devices. Trained as a pharmacologist, she has a unique 18...

Howard leads and manages the overall operation of the Innovation Centre. He brings experience from the academic, industry and financial sectors focused on developing businesses around emerging technology. He has founded, held executive management positions, acted as Member of the Board of Directors ...

Sharon is a passionate and respected global health leader with extensive experience in business and product development.  As Head of JLABS @ Shanghai, Sharon is responsible for setting the strategic direction and overseeing all operational activities for JLABS @ Shanghai, the first Johnson &...

Hitesh is the Asia-Pacific Market Access Director for Janssen's  Multiple Myeloma portfolio. In this role, he focuses on the integrated access and pricing strategies for Janssen's key assets in Multiple Myeloma including Darzalex, CAR-T as well as future pipeline products. Prior to...

Allen Chang is the Co-founder and Chief Executive Officer of Atgenomix Inc., an enterprise Bio-IT platform that scales genome sequencing analysis by high performance parallel computing in the cloud. By the inspiration to accelerate precision medicine, Allen cofounded Atgenomix and dedicates to...

Arani Chatterjee completed his graduation from CMC, Vellore and post-graduation from NIMHANS, Bangalore. He has a Postgraduate Certificate in Management from IIM, Indore. Before joining Aurobindo Pharma, he was at Biological E, Hyderabad for 3 years, Panacea Biotec, New Delhi for 9 years and...

Dr. Chen Qingfeng is currently a Senior Principal Investigator at the Institute of Molecular and Cell Biology (IMCB) at Singapore’s Agency for Science, Technology & Research (A*STAR). Alongside his role at IMCB, he is also holding Joint positions with local research institutes and hospitals and ...

PJ Chen currently is senior vice president of APRINOIA Therapeutics responsible for overall portfolio delivery, PI site network, medical and regulatory affairs. Previously, PJ served as president, United Biopharma (UBP) China responsible for clinical development strategy, R&D lab/pilot factory...

As Vice President of Clinical Operations and Regulatory Affairs at Cerecin, a brain health company, Lilian leads all clinical and regulatory operations for Cerecin, including the clinical development for migraine, infantile spasms, Alzheimer’s disease and other CNS indications. Lilian is also an...

Stephen Christopher brings to the Medical Affairs industry a thorough, diverse & deep range of insight having worked across Clinical practice, Medical Affairs and Clinical Development for 14 years.

Fredy Chu is the Vice President of GenScript ProBio. He has 30+ years of experience in the pharma/biologics quality management sector in various companies such as Baxter, Collagen, ChemPartner, PharmaEssentia, Kanghong, Xoma, Fibrogen prior joining GenScript ProBio. He graduated from Iowa State...

Dr. Harish Dave is Chief Medical Officer for AUM Biosciences. He is a Board-Certified Hematologist and Oncologist with 40+ years in basic science, academia and industry, as Principal Investigator, Institutional Research Head and Chief Medical Officer, overseeing basic and clinical research. He has...

Ishita is the Executive Director with EY’s Consulting Practice. She has a strong focus on Life Science and Healthcare sectorAn entrepreneur herself, she has over 15 years of experience in supporting businesses expand their presence in Asia Pacific. She has worked extensively on topics like New...

Mark Diamond has over 30 years experience in the pharmaceutical and biotechnology industry. Before joining Antisense Therapeutics Limited as MD and CEO in 2001, Mr. Diamond was employed in the US as Director, Project Planning/Business Development at Faulding Pharmaceuticals. Prior to this he held...

Dr Carl Firth is Founder and Chief Executive Officer of ASLAN Pharmaceuticals.Prior to founding ASLAN, Carl was Head of Asia Healthcare at Bank of America Merrill Lynch, supporting public and private financing of healthcare companies and advising on M&A transactions. Prior to joining the...

Wei Ling is the Senior Vice Presidentof Investments with Xeraya Capital, a life science venture capital and privateequity investor. Her experience spans across both privateequity and venture capital investment. Previously, she was with Aureos Capital, a globalmid-cap emerging markets private equity ...

Dr. Ogan Gurel holds academic appointments as a Visiting Professor at the Solbridge International School of Business and Visiting Teaching Professor at DGIST (Daegu Gyeongbuk Institute of Science & Technology), with previous DGIST positions as Vice-Chair & Distinguished Invited Professor in ...

As a member of KPMG's Global Healthcare & Life Sciences Centre of Excellence, Chris is presently based in Singapore looking after developments in the Asia-Pacific region. Prior postings have included Europe, US, and Brasil. With experience across a range of geographies and project...

A Cardiothoracic & Vascular Surgeon Lecturer of Faculty of Advanced  Technology & Multidisciplinary, Universitas Airlangga. Deeply in Passionate & Compassions in Digital Health Technology

Sheng Ting Hung is the Chief Scientific Officer at Medfluid, a biotech company using microfluidics to provide diagnostics for infectious diseases and quantitative antimicrobial susceptibility testing. Sheng develops novel microfluidic technologies for biomedical applications in Medfluid and...

Mrunalini is an accomplished professional with over 12 years of experience in diverse roles across CRO, IT, pharmaceutical & research organizations where she has exhibited expertise in steering global CDM projects conducted across US, EU & APAC to successful completion. Currently, she ...

Rajasa Jialdasani is the Medical Director at Qritive where she is responsible for generating a pipeline of scientifically relevant artificial intelligence modules for histopathology diagnosis in a clinical as well as research setting. She also oversees the healthcare industry partnership function.A ...

Lisa Palladino Kim, is the Director of Capstone and Lecturer at Rutgers School of Health Professions MS in Clinical Research Management (formerly Clinical Trial Sciences) Program. Lisa has 15 years of pharmaceutical expertise, with a concentration in Clinical Operations, which allowed her to gain...

Mr. Tang Kok Mun is the CEO of Biogenes Technologies Sdn. Bhd., a Malaysian-based company focusing on development and commercialisation of aptamer-based molecular diagnostic technologies for applications in human healthcare, animal healthcare, agricuture, aquaculture, food safety and pollution...

Naheed Kurji is a Co-founder, and the President and CEO of Cyclica, a Toronto-based venture-backed biotechnology company. Cyclica has built and commercialized an integrated AI-augmented drug discovery platform that embraces the complexity of disease to accelerate the discovery of better...

Andrea has 11 years’ experience in health economics & market access/reimbursement in both consulting (Vista Health, IMS Health) and Industry (Pfizer Italy, Janssen UK and AbbVie Australia).He is responsible for the HTA- & HEOR-related offering of Vista Health, from product and business...

Hang Le believes in harnessing the power of data and technology innovations in precision medicine to improve patients' lives and transform healthcare systems. She is currently Access Lead for Foundation Medicine and Personalized Healthcare at Roche Pharma International, covering APAC...

Andy has more than 25 years of biomedical research and biopharmaceutical industry experience with proven track records in global drug development in multiple therapeutic areas, alliance management, and business development. He previously held management positions at GSK, Abbott and most...

HyoJin Lim is the director of Global team in CliPS Co., Ltd., working on extending CliPS’ collaboration and partnering through clinical research and biological drug development business. Before joining CliPS, she was the project director of ClinipaceWorldwide and the Sr. Project manager in INC...

Dr Lim has dedicated a large part of his research focus on molecular biomedicine. He is a strong advocate of cellular wellness and stem cell medicine. For over more than 20 years, he has fervently pursued his scientific interests on bioactive molecules that govern and regulate cellular pathways...

Martin Lim is the founder and CEO of ONWARD Health Research, a Singapore-based, seed-stage startup developing a platform that enables hospitals and physicians in Southeast Asia to conduct world-class clinical research. Prior to this, Martin spent five years as the COO of a multi-specialty...

Weng Khong is Director of Bioinformatics at the SingHealth Duke-NUS Genomic Medicine Centre, and Assistant Professor in the Cancer & Stem Cell program at the Duke-NUS Medical School. He obtained his PhD in Genetics from Cambridge University in 2012 and subsequently conducted his...

Yen-Chu Lin obtained his PhD from ETH Zurich (Switzerland) working at GisbertSchneider lab where he pioneered in the peptide research field adopting machinelearning approaches combining with experimental-lead strategies or withpharmacology-driven concepts to multidimensionally design peptides with...

At SGInnovate’s inception, Augustus was tasked with driving the fund's investments in healthcare, a new vertical at the time. When he left in 2020, healthcare investments had grown to represent the largest vertical in the overall portfolio and SGInnovate itself is recognised as one of the most...

Dr Timothy Low currently serves as a member of the hospital’s Board of Directors of Farrer Park Hospital.He is also Head of Healthcare Investment at Pavilion Capital ( A Temasek Holdings company ).Prior to this, Dr Low served as CEO of Farrer Park Hospital, a private acute tertiary institution...

Viren Mahurkar, Founder and Chairman at HitchinRock Advisors, specializes in deals, investments and economics in the healthcare sector.  Over the course of his career, Mr Mahurkar has held senior leadership positions in both healthcare and investment banking.  He brings a global...

After 20 years in executive role, managing industrial businesses in Europe and Asia for different corporations, I decided two years ago with a partner Fabrice Dumont Dayot (CEO of SP Groups www.spgroups.ch) to start C-CUBE (www.c-cube.com) in Vietnam.We brought all knowledge and best practices...

Joseph is the Managing Partner of Verge HealthTech Fund focusing on early stage healthcare technology companies relevant to emerging markets. Prior to this, Joseph was a scientist researching new cancer therapies, a medical device entrepreneur, and a management consultant for Oliver Wyman where he...

Associate Professor Tam Nguyen PhD MBA FRSPH FAIM MAICD is the Deputy Director of Research at St Vincent's Hospital Melbourne responsible for research strategy, research business development and research administration. Tam leads a dynamic team dedicated to providing innovative solutions to...

Dr Duc-Viet Nguyen received his PhD in 2016 under NUS Graduate School for Integrate Sciences and Engineering (NGS) Scholarship. His research focuses on nano/micro structures and fabrication, advanced and smart materials for drug delivery, diagnostics, biosensing. He has been enrolled in various...

Evelyn is a pharmacist by training and has over 13 years of progressive experience in the pharmaceutical industry. Taken on sales, marketing, medical, strategy and commercial operations roles for Singapore and Asia-Pacific (APAC), she has successfully launched and managed blockbuster brands in both ...

Dr. Phan is author of more than 80 publications in international peer-reviewed journals, two book chapters, has more than 40 granted patents and founder of multiple successful biotech and healthcare companies in Singapore and Vietnam. His recent innovative research work is the discovery of a novel...

Raj has 20 years of experience in healthcare advocacy, policy and governance. As Executive Director of Rainbow Across Borders, he has created and led specific illness patient access programmes and campaigns. He has also initiated and built an extensive network comprising policy makers, industry...

Birgit Reitmaier is Head of Access to Innovation APAC at the Biopharma division of Merck. In this role she scouts for and transacts on collaboration opportunities in the APAC region. She has worked in business development at Merck since 2009. Prior to that Birgit worked for a skin-research...

Passionate about improving patient outcomes through data and technology. Over 10 years of experience in Digital Health, with local, regional and global roles across Latin America, Europe and Asia in big and mid-size Pharmaceuticals.

Dr. Sekar secured his PhD form Newcastleand Oxford University (UK), as a Dorothy Hodgkin Postgraduate Fellow, funded byJanssen Pharmaceuticals (formerly J&J PRD), Belgium and BBSRC (UK). Dr.Sekar took up a postdoctoral fellowship with Janssen Pharmaceuticals,Belgium extending the bio-imaging...

Kulbir Sandhu is a APAC regional head of Digital Strategy and Innovations with Roche Pharma. Kulbir is an experienced leader with a track record of new product creation and strategic solution development for innovative healthcare technologies and consumer electronicsproducts across Asia Pacific...

Dr. Marinella Sandros currently is the Senior Global Product Manager for reagent services at GenScript. Prior to joining GenScript,she worked as the business development manager for life Sciences and SPRi product manager at HORIBA Scientific from 2015-2019. Previously, she held a full time...

Levana is the co-founder and CEO of Nalagenetics. She was trained in biochemistry in University of Southern California, genetics in Genome Institute in Singapore, and business in Harvard Business School.

Aaron is CSO of the Pharma Vertical at Twist Bioscience.  Prior to Twist, he served as Chief Scientific Officer of LakePharma, leading the California Antibody Center, which discovers novel antibody therapeutics for its clients. He also oversaw all discovery research functions both as Vice President ...

Melissa Saw is currently the Global Head of Digital Partnerships in Bayer.  In this capacity, she leads global enterprise collaborations with external partners as part of Bayer’s Digital Transformation journey.While at Bayer, she has held various positions in Sales, Marketing and now in Digital...

Sebastian Schäfer is a Co-founder of Enleofen Bio, a Singaporean biotech company developing first-in-class antibody therapeutics for the treatment of fibro-inflammatory diseases.

Vidhu works in Chief Medical Office supporting Global Pain Category for GSKCH. She has been working with GlaxoSmithKline for close to a decade and is based out of Singapore. She has extensive therapeutic experience across Pharma, Biotech and Consumer Healthcare including regional and global...

Abhishek has more than a decade of healthcare experience, having previously co-led an early stage fund as a venture capitalist, and held leadership positions in his healthcare family businesses. He holds a B.S. in Chemical and Biomolecular Engineering from Georgia Tech and an MBA from the Indian...

Akanksha is the Operations & Quality Lead at QuikPath. She ensures that the Company operations adhere to regulatory compliance. She assists in maintenance of business processes to accelerate growth of the organization. She has significant Quality experience in the Medical device...

Over 27 years of experience covering API (Non Sterile & Sterile) Production in the Pharmaceutical sector. Keen administrator with recognized proficiency in managing complete production operations entailing production, quality, safety, maintenance, project management for various active...

Dev is the Foundation Medicine (FM) Transformation Lead for Roche’s Pharma International network and is based in Singapore. He has extensive experience in commercial and market access functions across markets and regions and his current role entails accelerating FM’s business across key global...

She has over 21 years of hands on leadership experience, primarily in Fortune 500 companies (Johnson & Johnson, Novartis and Arthur Andersen) spanning across 18 countries in a variety of roles including P&L ownership, Strategy and Digital Transformation. With strong Industry networks, a...

Rohit Singh, CFA has more than a decade experience in PE/VC investments and front end investment banking. As an investment banker, he has represented clients from Asia, Europe and the US, advising them on cross border acquisitions worth over USD 1 billion and as a VC he has been part of investments ...

Dr Sinha is a pharmaceutical physician with over 20 years experience. He is currently Senior Vice President and Medical Director, Hetero Group of Pharmaceutical companies, as well as Global Head of Department - Clinical trials, Medical Affairs and Pharmacovigilance since 2011. He earlier worked as...

Dr Huren Sivaraj is a Medical Oncologist and physician-entrepreneur. He is the CEO and Co-founder of Oncoshot - a Cancer Clinical Trial Matching Tool and Collaborative Platform for Oncologists.  As an Oncologist, Dr Huren cares for patients with a broad range of solid tumour diagnoses and was a...

Dr. Stolzenberg is a post-doctoral researcher at Free University Berlin with the expertise to solve molecular mechanisms of proteins using Molecular Dynamics simulations and Machine Learning, publishing in journals like Nature, PNAS, and Nature Communications. Originally trained as a physicist at...

Kasia is a co-founder and Chief Executive Officer of ardion, clinical-stage biotech company focused on developing first in class therapies for autoimmune diseases. With 17 years experience in business building, sales, marketing, operations, P&L oversight, for both start-up and growth...

Vincenzo Teneggi (MD) Senior Medical Director Experimental Drug Development Centre (EDDC) A*STAR, Singapore   Vincenzo has over 30 years of global experience of drug development within major pharmaceutical companies as...

Dennis has more than 10 years of experience working in both Europe & Asia in 2 industries, Pharmaceuticals & medical devices. He is focused on improving clincial trials, the patient experience and delivering improved outcomes. 

Adrian obtained his B.Sc. (1st Class) from the National University of Singapore. He completed his Ph.D. on stem cell biology with Ludovic Vallier at the University of Cambridge, under an A*STAR Scholarship.Concurrently, he was also an Honorary Cambridge Commonwealth Trust Scholar. He then trained...

Dr Peter Tobin is the APAC Medical Director of Oncology at Merck. Peter has worked in the pharmaceutical industry in a variety of roles including communications, market access, and medical affairs. He has worked on bringing new medicines to people living with cancer including...

Hsien-Hui brings his in-depth knowledge and experience in the Business Development and Venture Capital spaces across Australia, Europe, Singapore and the US.As Executive Director, Venture Investing, Hsien-Hui oversees SGInnovate's investments efforts, which target high-potential, deep tech...

Karen Alparce-Villanueva has over 20 years experience in communications & policy work in the pharmaceutical industry  She left her corporate job 5 years ago to devote her long experience in health advocacy to advancing patient rights through her pro-bono work for the Philippine Alliance of...

Nilesh Wadhwa is Director New Venture & Transactions at Johnson & Johnson Innovation, Asia Pacific. In this role, he is responsible for establishing networks within local and regional biotech ecosystems and forging collaborations with academic...

Tina led a distinguished career in oncology spanning over 20 years, demonstrating her strong leadership in the biopharmaceutical industry, clinical practice and translational medical research. She has an extensive background in immunotherapeutic drug and assay development as well as...

Jeff has more than 20 years' experience working with leading organisations across the life sciences and healthcare value chain in Asia Pacific. His roles have encompassed executive positions in the biopharma industry with Novartis and AbbVie as well as leadership of Big 4 consulting...

Tim Xiao, CFA, FRM, is a Principal at Delos Capital since its inception in 2014 and has over 12 years’ experience in investment banking and life sciences investment. Tim started his career as an investment banker at China International Capital, and later joined Goldman Sachs where he completed a...

A materials engineer with a calling to bring the cutting-edge of technology to market in a progressive yet sustainable way. Currently aiding in the commercialization of disruptive Aerogel insulation technology for cold-chain packaging to ensure safe and effective transport of life-saving drugs and...

Dr Yeo Jing Ping is the Director for Research Integrity, Compliance and Ethics in Singapore Health Services Pte Ltd.  She leads a team that is responsible for ensuring proper oversight of research ethics, compliance, quality and integrity in the SingHealth Group.She has more than 20 years of...

Alexander Zach is Senior Vice President, Global Head Market Access, Policy & Pricing at Biocon Biologics UK Ltd, based in Singapore. He was previously Head of Market Access, Policy & Pricing, Region Asia Pacific for Roche, a company that he worked with growing responsibility and remit at...

Prior to joining Neogenomics, Weiwei worked for Kingmed Diagnostics for over 9 years. She was Vice President responsible for the Clinical Genome Center and Pharma Services. She had been Administrative and Technical Director of the Clinical Genome Center and General Manager of the Clinical Trial...